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Oral Contraceptivesand ReproductiveCancers:
Weighingthe Risksand Benefits
By Ann L. Coker,Susan Harlap and JudithA. Fortney
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Methodsofdecisionanalysislead userswith"nonusers,"
thatthe
recognizing
ceris diagnosedmorefrequently
inyoung policy.8
groupwith
women who have used oral contracep- to numerical"whatif?"calculationsthat nonusersarea heterogeneous
oftheprojected
out- respecttotheircontraceptive
use.
tives.3The existenceofa causal relation- allowthecomparison
decision.
To conductthisanalysis,we required
ship betweenpill use and breastcancer comesand valuesofa particular
bysiteand
would raisequestionsaboutthebenefit- In our decisionanalysis,thedecisionis dataon theincidenceofcancer,
aboutwhethertouse oralcontraceptives. age,theprevalenceofpilluse byage,and
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For each typeof cancer,we used the
Theseproductswerecalculatedforall
incon- age intervalsup totheintervalincluding
prevalence
ofpilluse byage-group
junctionwiththerelativeriskfororalcon- themean age of canceronset.Since the
on thespecific
cancerin- meanage atonsetvariesbycancersite,we
traceptives'
effect
thesecalculationsseparately
cidence to computethe cancer-specific performed
Age-group
Cancertype
incidencerates(per100,000)forpillusers bycancersite,and summedthemtoyield
?60
15-49
50-59
lifelost
and nonusers.Wethencomputedcumu- thepotentialyearsofcancer-free
the
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fivecombined.
taking
the
sum
of
for
all
cancers
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rates
by
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1.00
1.00
1.20
Breast
1.00
1.00 yearage-specificcancerincidencerates did thesecalculationsseparately
1.20
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fororal
1.00
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0.75
Ovarian
usersand nonusers,apply1.00 over the lifetime(through85 or more contraceptive
0.75
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Endometrial
thesum by five, ing to bothgroupsthemeanage ofcanyears)and multiplying
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yearsofcancer-free
Thecancerincidenceratesused forthis difference
morethan 10 yearsamong women foles- analysisarethosereported
forallraces.Al- lifelost betweenthe two user groups,
lowed after1980.12Fora conservative
we haveused a relativeriskof1.2 thoughcancerincidenceratesdo varyby whichindicatedthenumberofyears(or
timate,
lifelostorgainedbeouranalysisby days)ofcancer-free
forpill use offiveor moreyearsamong race,we chosetosimplify
women youngerthan50 and a relative usingaggregateorsummarycancerinci- cause ofpilluse.
riskof1.0forwomenaged 50 and older. dence ratesforU. S. womenofall races.
to estimatetherateofcervical Sinceitis notcertainthattherelationship Decision Tree
Similarly,
canceramong oral contraceptiveusers betweenpilluse and eachcanceris mod- In thedecisiontreeused in thisanalysis,
risk ifiedby race,we feelthatthisapproach therearetwochoices-to use oralcontrayoungerthan50,we applieda relative
oftherisks ceptivesforfiveor moreyears,or notto
estimateof1.2tothecrudeincidencerate providesa reliablecomparison
ofpilluse on theincidenceof do so. Whetherwomen in need of conforcervicalcancer,13
and a relativeriskof andbenefits
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traceptionelectto use or notto use oral
risk reproductive
1.0forwomenolderthan50.A relative
eachhas fivepossibleoutcontraceptives,
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inthecancerincidence
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setis basedonthefive-year
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Eachcomparison
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cancer,
cancerrates,we appliedthe cidenceassociatedwithpilluse.
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to theage-specific
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risks wererankedas follows:0.8 forendomeuse offiveyears therefore,
lenceoforalcontraceptive
ormoreinduration,
byage.Wewereable should notaffectour selectedcancerin- trialcancer,0.6forcervicalcancer,0.4for
no long-term breastcancerand 0.2forovariancancer.
tocalculatethenumberofpillusersatrisk cidenceoutcomes.Further,
We comparedthetwobranchesofthe
ofpilluse on cardiovascular
disease,
ofpill-related
cancerusingtheU. S. age- effect
specific
populationofwomenandtheage- the outcome most stronglyassociated decisiontreeby calculatingthecancerspecificproductsofthecumulativeincispecificprevalenceoforalcontraceptive withthepill,has beenreported."5
dence and the correspondingset of
use offiveyearsormore.
LifeLost weights.By convention,this summed
The numberofpill users actuallyde- PotentialYearsofCancer-Free
velopingcancerwas calculatedusingthe Our calculationofthepotentialyearsof productis termedthe"expectedvalue."
tothe The largertheexpectedvalue, themore
lifelostis almostidentical
cancerincidence,therelative cancer-free
age-specific
riskestimatesforthepill-cancer
relation- methodused by theCentersforDisease favoredthedecision.
forcalculating
andPrevention
pershipandthenumberofwomenatrisk(i.e., Control
is that Sensitivity
Thedifference
oflifelost.16
Analysis
who had used the pill forfiveyearsor son-years
notthein- The assumptionsregardingthestrength
more).Thecancerrateswerecalculatedby ouroutcomeis cancerincidence,
dividingthenumberoforalcontraceptive cidenceofcancerdeath.To computethe oftherelativeriskestimatesthatcharaclifelost,we terize the relationshipbetween reprouserswithcancerbytheoverallnumber potentialyearsofcancer-free
use
foreachuserornon- ductivecancerand oralcontraceptive
of pill users. (The formulaswe used in multiplied
(separately
and arecurrently
subjecttomuchdebate;thus,
age-specific
thesecalculations
appearintheappendix.) usergroup)thefive-year
incidenceratesbythedif- we chose to conducta sensitivity
analycancer-specific
*To simplifytheanalysis,we ignoredthepossibilityof
ferencein themean age at canceronset sis,inwhichseveralrelativeriskestimates
morethanone canceroccurringin thesame woman, so
betweenpilluse and
amongthenonusersand bythemidpoint fortherelationship
theprobabilityofremainingfreeofcanceris one minus
breastand cervicalcancercould be apoftheage interval.
thesum oftheprobabilitiesofthefourcancers.
Table 1. Estimated relative risks of reproductive cancer fororal contraceptive use of five
years or more,by typeof cancer, according to
age-group
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plied. (The estimatedrelativerisksfor
ovarianand endometrial
cancerassociated withpilluse did notchange.)
Whenconducting
thissensitivity
analysis,we used threerelativeriskestimates
other than those we consideredmost
betweenpill
probablefortherelationship
use andbreastcancer.A relativeriskof1.5
correspondedto thatreportedin a metaanalysisforpill use of 10 yearsor more
a relaamongpremenopausalwomen;18
tiveriskof1.1used forwomenofall ages
correspondedwiththatreportedby the
WorldHealthOrganization(WHO) in a
large,multisite,
hospital-based
case-controlstudy;19
and a relativeriskof1.0 indicatedno increasedriskofbreastcancer
associatedwithpilluse.
Therelativeriskestimateof1.2fororal
use and cervicalcancerwas
contraceptive
selectedas a bestguess forthisrelationship,giventhecontroversy
surrounding
whetherpill use is causally associated
withcervicalcancer.We also applied the
relative
riskestimates
fortherefollowing
lationshipbetweenpill use and cervical
cancer:A relativeriskof1.5corresponded to thatreportedin one studyofeverwhilea relativeriskof
usersofthepill,20
1.0corresponded
withreports
suggesting
no causal relationshipbetweenpill use
and cervicalcancer.21

weretocausea 20%increaseinbreastcan-

Table 2. Excess reproductivecancers per cer,a 50% increaseincervicalcancer,and
100,000oral contraceptiveusers, compared
withnonusers, and numberof cancer-free a 50% decreasein bothendometrialand
ovarian cancers (Table 3, line 1), users
days lostor gained,bytypeofcancer

would experience177 additionalreproductivecancersper 100,000usersby age
butovertheirlifetime
50,
theywould ex-44
Total
perience
only48 additionalcancersper
Breast
+374
Cervical
+67
100,000users.Pill users would lose one
-215
Ovarian
cancer-free
day,comparedwithnonusers.
Endometrial
-270
Usingbothsetsofweights(thosebasedon
survivalprobabilitiesand on thecancer
and per- outcomerankings),
thedecisiontouse oral
cancer,
comparedwithnonusers,
haps one day freeofcervicalcancer.Pill contraceptives
wouldbe as favoredas the
userswould gainfourdaysfreeofovari- decisionnottouse them(expectancy
valan cancerandfivedaysfreeofendometrial ues forsurvivalof .942and .942,respeccancer,comparedwithnonusers.
tively,and expectancyvalues fordesirThe decisionto use thepill would be abilityof.882and .882).
tothedecisionnottouse
slightly
preferred
Changingtherelativeriskestimatefor
it.The expectedvalue forpill use calcu- pill use and cervicalcancerto 1.2 (i.e.,a
latedusingthedecisiontreeand thefive- 20% increasedrisk)would resultin pill
as weights(.943) users potentiallyexperiencing86 more
yearsurvivalprobabilities
was virtually
thesameas thatfornonuse cancersper100,000
byage 50,but44 fewer
(.942).Expectedvalues calculatedusing over theirentirelifetime.Users would
thesame decisiontreebutusingweights gainone cancer-free
day,and thedecision
showthat to use thepillwould be equallyfavored,
basedonthedesirability
ranking
forpill use and nonuse,thefourcancer comparedwithnonuse.
outcomeswereequal (0.882),indicating
no
Finally,ifpill use werenotassociated
in thechoiceofuse ornonuse. withcervicalcancer,pilluserswould exdifference
Table 3 presentssensitivityanalyses perience19 additionalreproductive
canshowinghow theseresultschangewhen cersper100,000byage 50,butexperience
different
sets of assumptionsare made 111fewercancersovertheirentire
lifetime.
abouttheeffect
ofpilluse on therelative Pill users would gain two cancer-free
riskforbreastand cervicalcancer,thetwo days, and the decision to use the pill
Results
inriskofde- reproductive
Table2 presents
cancersforwhichthesize of wouldbe equallyfavored(Table3,line3).
thedifference
riskremainscontrover- Ifwe assumethatoralcontraceptive
use
veloping a reproductivecancer over a thepill-associated
woman's lifetime(up to age 85 or older) sial.Threesetsofassumptionsregarding is associatedwitha 50%increaseinbreast
ofa worst-case
associatedwithpill use of fiveyearsor therelativeriskestimatesforpilluse and cancer(an illustration
scemore,comparedwithnonuse.Underthe breastcancerwereapplied:a 20%increase nario,based on the1990meta-analysis22),
thesizeandnature inbreastcancerriskamongwomenaged pill users would experiencea range of
assumptions
regarding
inriskamongwomen 528-687additionalreproductive
oftheestimatedrelativeriskpresentedin 15-49,
a 50%increase
cancers
Table 1,pill users would experience44 aced 15-49 and a 10%
fewerdiagnosesofcancerper100,000
users increase for women Table 3. Excess cancers among womenyoungerthan50 and
thanwouldnonusers.
Acrosstheirlifetime, throughouttheir life- throughouttheirlifetime;numberof cancer-freedays lost or
gained;and expectedvalues foruse and fornonuseoforalconpilluserswouldexperience374addition- time.For each of these tiVaceptives,
ranking;all accordingto
bysurvivaland desirability
al breastcancersper100,000usersand 67 threegroupings,
we also excess breastand cervicalcancerriskassociated withoralconadditionalcervicalcancersper 100,000, present findings for traceptiveuse offiveyearsor more
Pilluserswould, threedifferent
assumpcomparedwithnonusers.
Cancer- Expectedvalues
Excesscancers
% excess
however,experience215 fewerovarian tionsregardingthecer- cancerrisk*
per100,000users freedays (use/nonuse)
based on:
cancersand270fewerendometrial
cancers vicalcancerriskassociSurvival Desirability
<50
Lifetime
atedwithpilluse: a 50%
per100,000thanwould nonusers.
Breast-20%
Table2 also presentstheperiodofcan- increaseamongwomen Cervical-50% 177
-1
48
.942/.942 .882/.882
-44
+1
86
.943/.942 .882/.882
cer-free
lifegainedorlostamongpillusers, aged 15-49,a 20% in- Cervical-20%
-111
+2
19
.943/.942 .882/.882
relative
tononusers.(Cancer-free
lifemea- crease among women Cervical-0%
suresthetimeuntilcancerdevelops,not aged 15-49 and no in- Breast-50%
-11
687
558
.941/.942 .879/.883
Cervical-50%
thetimeuntildeath.)As thistableclearly creasedriskforwomen Cervical-20%
476
.942/.942 .879/.883
596
-9
intheperiodofcan- ofanyage. Theestimat- Cervical-0%
shows,thedifference
.942/.942 .880/.883
528
400
-8
cer-free
lifelostorgainedamongpillusers ed relativerisksforpill Breast-10%
.940/.942 .875/.882
90
1,156
0
andnonusersis so smallthatitcanbe mea- use and endometrial Cervical-50%
-2
.940/.942 .875/.882
1,065
+1
sured only in days. Overall,a pill user and ovariancancer(0.5) Cervical-20%
+2
.940/.942 .875/.882
-69
998
Cervical-0%
wouldgainonedayfree,
onaverage,from wereheldconstant.
therisks
andendometrial
cancerareassumedtobe50% (i.e.,a
forovarian
In allscenarios,
alltypesofreproductive
cancerconsidered. If oral contraceptive 50%
reduction).
Userswouldlosesevendaysfreeofbreast use offiveyearsormore
1993
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Excesscancers

Cancer-free
days
+1
-7
-1
+4
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methods,
otherlessrebyage 50,dependinguponthe cervical cancer is as controversialas used IUDs,barrier
per100,000
ofthese
increasethe liablemethodsora combination
assumedlevelofpill-associatedcervical whetheroralcontraceptives
inthesen- methods,and women who neverpraccancers riskofbreastcancer.Therefore,
cancerrisk,and400-558additional
We chose thishetrelativerisksfor ticed contraception.
analysis,different
Compared sitivity
acrosstheirlifetime.
per100,000
withnonusers,pilluserswould lose 8-11 bothbreastand cervicalcancerwereused. erogeneouscomparisongroupforseverinmanywaysitis similar
The We choseto presentresultsbased on the al reasons:First,
daysduringtheirlifetime.
cancer-free
reportfroma hospital-based to thetypesofcomparisongroupsused
decisiontouse thepillwould be equally controversial
ofa in themajorityofstudiesofpill use and
studyas a presentation
relative
tononuse,whensurvival case-control
favored,
whilethe worst-casescenario.24
(As was notedin a cancer;*second,itis a comparisonmore
areusedas weights,
probabilities
thechoiceofa easilyunderstoodbyconsumers.
favor subsequentpublication,25
weightswould slightly
desirability
Our analysisconsidersonlyreproduchospital-basedcontrolgroupmay have
thedecisionnottouse thepill.
are asso- exaggeratedthe relativerisk estimate, tivecancer.Pilluse has manyotherhealth
Whetheroralcontraceptives
includinga reductionin therisk
ciatedwithan excessbreastcancerriskin sincehospitalizedwomenmayhavecon- effects,
anemia,ovariancysts,
pilluse.)There- ofirondeficiency
womenolderthan50 remainsunclear.To ditionsthatcontraindicate
fromthesen- uterinefibroids,benignbreastdisease,
assessthecancerimpactshouldanypos- fore,theestimatesresulting
disease and ectopic
analysisusinga 50%increasedrisk pelvicinflammatory
sibleincreasein breastcancerriskbe not sitivity
as well as an increasedrisk
years, ofbreastcanceramongyoungerwomen pregnancy,27
exclusivetowomen'sreproductive
themostextreme
es- of cardiovascular disease, primarily
we also presentanalysesthatassumeoral shouldbe considered
use is associatedwitha 10% timateofriskassociatedwithpilluse,and amongwomenwho smokeorthosewith
contraceptive
othercardiovascularriskfactors.28
excessriskofbreastcanceracrossall ages. perhapsan overestimate.
Thisanalysisdid notconsiderthepoFinally,we used therelativeriskestiIn such a case, users would experience
effects
ofotherriskfacbytheWHO, of1.1fororal tentialsynergistic
anywherefrom90 moreto 69 fewerre- mate,reported
ofcancerorpariuse andbreastcanceramong tors(e.g.,familyhistory
productivecancersbyage 50,depending contraceptive
betweenpilluse and
were ty)ontherelationship
on cervicalcan- womenofallagesbecausetheresults
on thepill-related
effect
large,well- theriskofreproductive
cancer.Itremains
andrelatively
cerrisk.However,userswouldexperience basedona recent
sucheffects
exist.Prelim998-1,156morecancersper 100,000dur- designed hospital-based case-control unclearwhether
Giventhatstudiesallowinga suf- inarystudiessuggestno synergismbedependingon theas- study.26
ing theirlifetime,
ontherisk
history
sumed pill-cervicalcancerrelationship. ficientlatencyperiodforpill-associated tweenpilluseandfamily
inolderwomenhave ofbreastcancer.29
To be cautious,howevUsers would gain only 1-2 cancer-free cancerdevelopment
candays. Based on bothsetsofweights,the notbeenpossible,we can onlyconjecture er,womenathighriskofreproductive
ofpilluse on breastcancer cershouldnotuse thesemodelstoweigh
decision not to use oral contraceptives thetrueeffect
theirriskofcancer,becausetheestimates
riskamongwomenolderthan50.
would be favored(Table3).
of1.1 presented
arebasedon theriskassociated
riskestimate
Weapplieda relative
relationshipfor withtheaveragepopulationofwomentoestimatetherisk-benefit
Discussion
lowerriskofcancer.
in- oralcontraceptives
onreproductive
cancer whoareata relatively
Estimatedmodelsofthehypothetical
Several authorshave systematically
cancersindicate ifthepilldidincreasetheriskofbreastcancidenceofreproductive
years.Under contrastedrisksand benefitsoforalconthat,at leastintermsofcancerincidence, cerbeyondthereproductive
Because itineach100,000
pillusers traceptiveuse on health.30
are a safeoptionfor thosecircumstances,
oral contraceptives
models the
more cludes in theirrisk-benefits
a rangeof998-1,156
birthcontrol,even aftertakingintoac- wouldexperience
cancersthannonusers,de- findingthatbreastcanceris diagnosed
count currentconcerns over whether reproductive
riskforcervical
can- morefrequently
amongpillusersyounger
youngpillusersaremorelikelytobe di- pendingontherelative
num- than45,recentworkbyDiana Petittiand
agnosedwithbreastand cervicalcancer, cerused.Thereasonfortheincreased
cancers
amongpillusers Deborah Porterfield3land by Martin
As thesensitivity
analysis(Table3) il- berofreproductive
is mostcomparableto our riskthedecisionwhethertouse oral whentherelativeriskof1.1is appliedto Vessey32
lustrates,
and Porterfield
esanalyses.Petitti
basedoncancerriskalone, womenofall ages is thatthemajorityof benefit
contraceptives,
ofdevelprobability
depends on theassumptionsone makes breastcancercases occuramongwomen timatedthelifetime
cancerforthree
betweenpilluse and olderthan50.Underthesameassumptions, opingany reproductive
abouttherelationship
cancer patterns
breastcancer.Wechosetobeginourdeci- pilluserswouldgainup totwocancer-freeregionswith different
riskfororal daysrelativetononusers.Sincethemajor- (WesternEurope,Asia and Centraland
sionanalysisusingtherelative
cancercases SouthAmerica),underthreesets ofasuse and breastcanceresti- ityofbreastand endometrial
contraceptive
sincethis occurafterage 50 and theestimateofpo- sumptionsregardingthesize and nature
matedina 1990meta-analysis,23
timelostmoreheavily of therelativeriskestimateforpill use
esti- tentialcancer-free
mightbe viewed as thebestcurrent
mate.Based on thisrelativeriskestimate weightstimelostbeforeage 65,pillusers and cancer.Althoughtheychose slightrelativeriskestimatesforpill
of1.2amongwomenyoungerthan50,the farebetterthannonusersonlyin termsof lydifferent
outuse and cancer,as well as a different
timelost.
decisionto use thepill is a betterchoice cancer-free
ofcanOne limitationof thisanalysisis our comemeasure(lifetime
probability
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Correction
In "TheAssociationofAIDS Educationand Sex EducationwithSexual
Behaviorand Condom Use Among
Teenage Men," by LeightonC. Ku,
FreyaL. Sonensteinand JosephH.
theminussignwas left
Pleck[24:100],
showninTable2 for
offthecoefficient
AIDS educationand numberofpartshouldbe -.305.
ners.Thecoefficient
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